Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and half year ended September 30, 2026.

GIN No. L24232PB1983PLC005426 GST No. 03AAACK6458M1ZB Phone : 91-8558820862 (Accounts) : 91-8558820863 (Admin.) D.L. No. 1800-0SP, 1804-B I.E. Code No. 1293001210 :91-9915743720 (Exports) KWALITY PHARMACEUTICALS LIMITED M.D. Mobile: 91-9814071215, 9814052314 E-mail : export@kwalitypharma.com Regd. Office: Village Nag KaIan, Majitha Road, Amritsar - 143 601 (INDIA) ramesh©kwalitypharma.com Website : www.kwalitypharma.com Date: November 05, 2026 The Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers Dalai Street, Mumbai-400001 Scrip Code: 539997 Subject: Intimation of Board Meeting under Regulation 29 of the SEBI ( Listing. Obligations and Disclosure Requirements), Regulations, 2015 Dear Sir/Madam, With reference to the above captioned subject and pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, November 12, 2026 at the registered office of the Company situated at Village Nagkalan, Majitha Road, Amritsar, Punjab-143601 at 10:30 A.M. 1) To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September, 2026. 2) To consider and transact any other business with the permission of the Chair. Further, in continuation of our intimation dated 28th September 2026 regarding closure of trading window, the Trading Window for dealing in the shares of the Company for all designated persons, their immediate relatives and other connected person(s) shall remain closed till 48 hours after declaration of Financial Results of the Company on November 12, 2026. Kindly take the same on records. Thanking You, Yours Faithfully, For Kwality Pharm e7-- - Ramesh Kumar Managing Director DIN: 00462656